Press "Enter" to skip to content

Lilly sees surging sales in contrast to obesity rival Novo

https://www.bloomberg.com/news/articles/2026-02-04/lilly-sees-surging-sales-in-break-from-weight-loss-rival-novo
The guidance was a sharp contrast to rival Novo Nordisk A/S, which warned investors Tuesday that its sales could drop as much as 13% this year on intensifying price competition in the weight loss market

More from BusinessMore posts in Business »
More from UncategorizedMore posts in Uncategorized »